1st Quarter - Report

IPOLICY SOLUTIONS for INVITAE INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H.R.2369 - VALID Act of 2023 FDA Proposed rule on LDTs

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions
LINDSEY TRISCHLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP)

Bills named: H.R. 2369 (118th)

Medicare/Medicaid MMM

No bill #: Precision Medicine Access for Kids Today Act

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions
LINDSEY TRISCHLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

S.2140: Patent Eligibility Restoration Act

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions
LINDSEY TRISCHLER —

Contacted: SENATE

Bills named: S. 2140 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.